Reata Pharmaceuticals News
Most Popular Reata Pharmaceuticals Story
Bardoxolone - 15 top blockbuster contenders
The drug: BardoxoloneThe disease: Chronic kidney diseaseThe developers: Reata and Abbott PharmaPeak projections: Several billion-plus When Richard Gonzalez took center stage a few days ago to talk up Read more...
Latest Headlines
- December 12, 2011
- October 25, 2011
- September 14, 2011
- September 6, 2011
- February 28, 2011
- September 23, 2010
- January 11, 2010
- January 8, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
